The ratiometric method identified Mut-drivers in breast cancers that were previously known drivers in other cancer types (such as KRAS, ARID1A, CDKN2A, PBRM1, KDM6A, MEN1, FOXP1, USP9X, BAP1, SMAD4). Here, SMAD4 is linked to breast cancer.